Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Modified Psoriasis Area and Severity Index, Thickness, and Inflammation of Psoriasis Vulgaris Lesions

NCT06887322 is registered in ClinicalTrials.gov with Universitas Padjadjaran as lead sponsor.

NCT NCT06887322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06887322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Modified Psoriasis Area and Severity Index, Thickness, and Inflammation of Psoriasis Vulgaris Lesions
Lead sponsor
Universitas Padjadjaran
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
February 13, 2025
Completion date
April 10, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, psoriasis vulgaris